Search research articles
Contact Us
Filters
Showing results (41-50 of 119) with videos related to
Page
of 12
Sort By:
Diabetologia
|
December 1, 1977
Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon
C Hendriksen, O K Faber, J Drejer, et al.
Advances in Biochemical Engineering/Biotechnology
|
February 6, 1999
Epoxide hydrolases and their synthetic applications
R V Orru, A Archelas, R Furstoss, et al.
Diabetes
|
January 1, 1978
Kinetics of human C-peptide in man
O K Faber, H Kehlet, S Madsbad, et al.
The American Journal of Medicine
|
February 1, 1994
Beyond futility to an ethic of care
L J Schneiderman, K Faber-Langendoen, N S Jecker
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 1, 1986
The effect of residual beta-cell function on the development of diabetic retinopathy
S Madsbad, E Lauritzen, O K Faber, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1979
Pancreatic beta cell secretion during oral and intravenous glucose administration
O K Faber, S Madsbad, H Kehlet, et al.
Gynecologic Oncology
|
April 1, 1991
Vulvar leiomyomatosis in a patient with esophagogastric leiomyomatosis: review of the syndrome
K Faber, M A Jones, D Spratt, et al.
Journal of Biotechnology
|
July 9, 1998
Purification and characterization of a highly selective epoxide hydrolase from Nocardia sp. EH1
W Kroutil, Y Genzel, M Pietzsch, et al.
Acta Endocrinologica
|
May 1, 1991
The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus
H J Gjessing, B Reinholdt, O K Faber, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
June 1, 1976
Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin
O K Faber, J Markussen, V K Naithani, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 119) with videos related to
Sort By:
Page
of 12
Diabetologia
|
December 1, 1977
Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon
C Hendriksen, O K Faber, J Drejer, et al.
Advances in Biochemical Engineering/Biotechnology
|
February 6, 1999
Epoxide hydrolases and their synthetic applications
R V Orru, A Archelas, R Furstoss, et al.
Diabetes
|
January 1, 1978
Kinetics of human C-peptide in man
O K Faber, H Kehlet, S Madsbad, et al.
The American Journal of Medicine
|
February 1, 1994
Beyond futility to an ethic of care
L J Schneiderman, K Faber-Langendoen, N S Jecker
Diabetic Medicine : a Journal of the British Diabetic Association
|
January 1, 1986
The effect of residual beta-cell function on the development of diabetic retinopathy
S Madsbad, E Lauritzen, O K Faber, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1979
Pancreatic beta cell secretion during oral and intravenous glucose administration
O K Faber, S Madsbad, H Kehlet, et al.
Gynecologic Oncology
|
April 1, 1991
Vulvar leiomyomatosis in a patient with esophagogastric leiomyomatosis: review of the syndrome
K Faber, M A Jones, D Spratt, et al.
Journal of Biotechnology
|
July 9, 1998
Purification and characterization of a highly selective epoxide hydrolase from Nocardia sp. EH1
W Kroutil, Y Genzel, M Pietzsch, et al.
Acta Endocrinologica
|
May 1, 1991
The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus
H J Gjessing, B Reinholdt, O K Faber, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
June 1, 1976
Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin
O K Faber, J Markussen, V K Naithani, et al.
Page
of 12